Formic acid treatment drastically reduces sporadic Creutzfeldt–Jakob disease and variant Creutzfeldt–Jakob disease infectivity in histological samples as tested in a high-sensitivity mouse bioassay
Journal of General Virology · 10.08.2026 · 107 (8)
DOI: 10.1099/jgv.0.002312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of General Virology, erschienen am 10.08.2026. Verfasst von Juan Carlos Espinosa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación en Sanidad Animal, CISA-INIA-CSIC, Madrid, Spain. Hauptthemen laut MEDLINE: Creutzfeldt-Jakob Syndrome, Formates, Prions. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Agencia Estatal de Investigación, European Regional Development Fund, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria.
Abstract (Originalsprache)
Formic acid treatment is widely used in diagnostic neuropathology to reduce the infectivity of prion-containing tissues; however, quantitative in vivo evidence supporting its effectiveness under routine laboratory conditions remains limited. Here, we assessed the impact of formalin fixation and formic acid treatment on the infectivity of type 1 sporadic Creutzfeldt–Jakob disease (sCJD) and variant CJD (vCJD) prions using highly sensitive transgenic mouse models overexpressing human-PrP M129 (Hu-Tg340) or bovine PrP (Bo-Tg110). Brain tissues were processed under conditions closely resembling standard histopathological workflows and tested as untreated, formalin-fixed or formalin-plus-formic-acid–treated inocula. Untreated samples produced short incubation times and full attack rates, whereas formalin fixation caused only a modest prolongation of incubation times. In contrast, formic acid treatment markedly extended incubation times and reduced attack rates for sCJD. Based on incubation-time interpolation, the estimated infectivity reductions were on the order of 4.4 log₁₀ for vCJD and 5 log₁₀ for sCJD. These estimates indicate a major reduction in infectious titre under the conditions tested, although residual infectivity was still detected. The findings support formic acid treatment as an important risk-reduction step in routine neuropathology workflows for the two prion strains examined.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Investigación en Sanidad Animal, CISA-INIA-CSIC, Madrid, Spain.
- Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Madrid 28040, Spain.
Förderung
- Agencia Estatal de Investigación
- European Regional Development Fund
- Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria
Zitieren
APA
Espinosa, J. C., Canoyra, S., Fernández-Borges, N., Marín-Moreno, A., & Torres, J. M. (2026). Formic acid treatment drastically reduces sporadic Creutzfeldt–Jakob disease and variant Creutzfeldt–Jakob disease infectivity in histological samples as tested in a high-sensitivity mouse bioassay. Journal of General Virology, 107(8). https://doi.org/10.1099/jgv.0.002312
Vancouver
Espinosa JC, Canoyra S, Fernández-Borges N, Marín-Moreno A, Torres JM. Formic acid treatment drastically reduces sporadic Creutzfeldt–Jakob disease and variant Creutzfeldt–Jakob disease infectivity in histological samples as tested in a high-sensitivity mouse bioassay. Journal of General Virology. 2026;107(8). doi:10.1099/jgv.0.002312
BibTeX
@article{Espinosa2026,
author = {Espinosa, Juan Carlos and Canoyra, Sara and Fernández-Borges, Natalia and Marín-Moreno, Alba and Torres, Juan María},
title = {Formic acid treatment drastically reduces sporadic Creutzfeldt–Jakob disease and variant Creutzfeldt–Jakob disease infectivity in histological samples as tested in a high-sensitivity mouse bioassay},
journal = {Journal of General Virology},
year = {2026},
volume = {107},
number = {8},
doi = {10.1099/jgv.0.002312}
}
EUVIMED